Hirtle Callaghan & CO LLC Novo Nordisk A S Transaction History
Hirtle Callaghan & CO LLC
- $2.57 Billion
- Q1 2025
A detailed history of Hirtle Callaghan & CO LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Hirtle Callaghan & CO LLC holds 18,561 shares of NVO stock, worth $1.19 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
18,561Holding current value
$1.19 Million% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding NVO
# of Institutions
1,768Shares Held
329MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.21 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$952 Million0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$797 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$793 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$764 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $145B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...